These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33237434)

  • 1. Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment.
    Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
    Pharmacol Rep; 2021 Feb; 73(1):269-277. PubMed ID: 33237434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study.
    Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
    Pharmacol Rep; 2021 Feb; 73(1):309-315. PubMed ID: 33025395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of GRIN1 and GRIN2A-D with schizophrenia and genetic interaction with maternal herpes simplex virus-2 infection affecting disease risk.
    Demontis D; Nyegaard M; Buttenschøn HN; Hedemand A; Pedersen CB; Grove J; Flint TJ; Nordentoft M; Werge T; Hougaard DM; Sørensen KM; Yolken RH; Mors O; Børglum AD; Mortensen PB
    Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(8):913-22. PubMed ID: 21919190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray.
    Qin S; Zhao X; Pan Y; Liu J; Feng G; Fu J; Bao J; Zhang Z; He L
    Eur J Hum Genet; 2005 Jul; 13(7):807-14. PubMed ID: 15841096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant association between the genetic variations in the 5' end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia.
    Zhao X; Li H; Shi Y; Tang R; Chen W; Liu J; Feng G; Shi J; Yan L; Liu H; He L
    Biol Psychiatry; 2006 Apr; 59(8):747-53. PubMed ID: 16476413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
    Tarabeux J; Kebir O; Gauthier J; Hamdan FF; Xiong L; Piton A; Spiegelman D; Henrion É; Millet B; ; Fathalli F; Joober R; Rapoport JL; DeLisi LE; Fombonne É; Mottron L; Forget-Dubois N; Boivin M; Michaud JL; Drapeau P; Lafrenière RG; Rouleau GA; Krebs MO
    Transl Psychiatry; 2011 Nov; 1(11):e55. PubMed ID: 22833210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recently-discovered NMDA receptor gene, GRIN3B, is associated with duration mismatch negativity.
    Lin YT; Hsieh MH; Liu CC; Hwang TJ; Chien YL; Hwu HG; Liu CM
    Psychiatry Res; 2014 Aug; 218(3):356-8. PubMed ID: 24814139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis of the genetic variants of the N-methyl D-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese.
    Chiu HJ; Wang YC; Liou YJ; Lai IC; Chen JY
    Neuropsychobiology; 2003; 47(4):178-81. PubMed ID: 12824739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-silico investigation of coding variants potentially affecting the functioning of the glutamatergic N-methyl-D-aspartate receptor in schizophrenia.
    Tsavou A; Curtis D
    Psychiatr Genet; 2019 Apr; 29(2):44-50. PubMed ID: 30664045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia.
    Itokawa M; Yamada K; Yoshitsugu K; Toyota T; Suga T; Ohba H; Watanabe A; Hattori E; Shimizu H; Kumakura T; Ebihara M; Meerabux JM; Toru M; Yoshikawa T
    Pharmacogenetics; 2003 May; 13(5):271-8. PubMed ID: 12724619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphisms in the GRIN1 gene 5' regulatory region and schizophrenia in a northern Han Chinese population and haplotype effects on protein expression in vitro.
    Liu YP; Ding M; Zhang XC; Liu Y; Xuan JF; Xing JX; Xia X; Yao J; Wang BJ
    BMC Med Genet; 2019 Jan; 20(1):26. PubMed ID: 30704411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology.
    Korinek M; Candelas Serra M; Abdel Rahman F; Dobrovolski M; Kuchtiak V; Abramova V; Fili K; Tomovic E; Hrcka Krausova B; Krusek J; Cerny J; Vyklicky L; Balik A; Smejkalova T
    Physiol Res; 2024 May; 73(Suppl 1):S413-S434. PubMed ID: 38836461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of Early Onset Schizophrenia: Associations of
    Poltavskaya EG; Fedorenko OY; Kornetova EG; Loonen AJM; Kornetov AN; Bokhan NA; Ivanova SA
    Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.
    Santos-Gómez A; Miguez-Cabello F; García-Recio A; Locubiche-Serra S; García-Díaz R; Soto-Insuga V; Guerrero-López R; Juliá-Palacios N; Ciruela F; García-Cazorla À; Soto D; Olivella M; Altafaj X
    Hum Mol Genet; 2021 Feb; 29(24):3859-3871. PubMed ID: 33043365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRIN2B gain of function mutations are sensitive to radiprodil, a negative allosteric modulator of GluN2B-containing NMDA receptors.
    Mullier B; Wolff C; Sands ZA; Ghisdal P; Muglia P; Kaminski RM; André VM
    Neuropharmacology; 2017 Sep; 123():322-331. PubMed ID: 28533163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles of
    Myers SJ; Yuan H; Kang JQ; Tan FCK; Traynelis SF; Low CM
    F1000Res; 2019; 8():. PubMed ID: 31807283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans.
    Mori F; Ribolsi M; Kusayanagi H; Siracusano A; Mantovani V; Marasco E; Bernardi G; Centonze D
    J Neurophysiol; 2011 Oct; 106(4):1637-43. PubMed ID: 21753020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
    Begemann M; Grube S; Papiol S; Malzahn D; Krampe H; Ribbe K; Friedrichs H; Radyushkin KA; El-Kordi A; Benseler F; Hannke K; Sperling S; Schwerdtfeger D; Thanhäuser I; Gerchen MF; Ghorbani M; Gutwinski S; Hilmes C; Leppert R; Ronnenberg A; Sowislo J; Stawicki S; Stödtke M; Szuszies C; Reim K; Riggert J; Eckstein F; Falkai P; Bickeböller H; Nave KA; Brose N; Ehrenreich H
    Arch Gen Psychiatry; 2010 Sep; 67(9):879-88. PubMed ID: 20819981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia.
    Hong CJ; Yu YW; Lin CH; Cheng CY; Tsai SJ
    Psychiatr Genet; 2001 Dec; 11(4):219-22. PubMed ID: 11807413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in subunit composition of NMDA receptors in animal models of schizophrenia by repeated administration of methamphetamine.
    Oka M; Ito K; Koga M; Kusumi I
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109984. PubMed ID: 32473191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.